From amounts made available to carry out this section, the Attorney General, through the National Institute of Justice, and in consultation with the National Institute on Drug Abuse, may make grants to public and private research entities (including consortia, single private research entities, and individual institutions of higher education) to evaluate the effectiveness of depot naltrexone for the treatment of heroin addiction.
(b) Evaluation program
An entity described in subsection (a) desiring a grant under this section shall submit to the Attorney General an application that—
(1)contains such information as the Attorney General specifies, including information that demonstrates that—
(A)the applicant conducts research at a private or public institution of higher education, as that term is defined in section
1001 of title
(B)the applicant has a plan to work with parole officers or probation officers for offenders who are under court supervision; and
(C)the evaluation described in subsection (a) will measure the effectiveness of such treatments using randomized trials; and
(2)is in such form and manner and at such time as the Attorney General specifies.
An entity that receives a grant under subsection (a) during a fiscal year shall, not later than the last day of the following fiscal year, submit to the Attorney General a report that describes and assesses the uses of that grant.
The table below lists the classification updates, since Jan. 3, 2012, for this section. Updates to a broader range of sections may be found at the update page for containing chapter, title, etc.
The most recent Classification Table update that we have noticed was Tuesday, August 13, 2013
An empty table indicates that we see no relevant changes listed in the classification tables. If you suspect that our system may be missing something, please double-check with the Office of the Law Revision Counsel.
Description of Change
Statutes at Large
LII has no control over and does not endorse any external Internet site that contains links to or references LII.